State Street’s SQZ Biotechnologies Company SQZ Stock Holding History

State Street’s Portfolio SQZ Stock Details SQZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-56,140	Closed	-$15.2K	–	4719
2023 Q2	$15.2K	Hold	56,140	–	–	﹤0.01%	4620
2023 Q1	$31.4K	Hold	56,140	–	–	﹤0.01%	4615
2022 Q4	$41.5K	Hold	56,140	–	–	﹤0.01%	4598
2022 Q3	$128K	Hold	56,140	–	–	﹤0.01%	4356
2022 Q2	$179K	Sell	56,140 -296,764	-84%	-$1.07M	﹤0.01%	4263
2022 Q1	$1.7M	Buy	352,904 +2,287	+0.7%	+$14.5K	﹤0.01%	3632
2021 Q4	$3.13M	Buy	350,617 +23,405	+7%	+$287K	﹤0.01%	3472
2021 Q3	$4.72M	Buy	327,212 +41,284	+14%	+$560K	﹤0.01%	3268
2021 Q2	$4.13M	Buy	285,928 +218,007	+321%	+$2.85M	﹤0.01%	3337
2021 Q1	$929K	Buy	67,921 +12,613	+23%	+$256K	﹤0.01%	3638
2020 Q4	$1.6M	Buy	+55,308	New	+$1.41M	﹤0.01%	3445

Other funds holding SQZ

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

BSB

Bangor Savings Bank Bangor, Maine $1.36B AUM 19.29% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

State Street's SQZ Position: Q3 2023 in Review

State Street sold out of SQZ Biotechnologies Company (SQZ) in Q3 2023, closing a stake of 56,140 shares — an estimated $15.2K sold.

State Street first reported a position in SQZ in Q4 2020 and held it in 11 quarters. The position peaked at $4.72M in Q3 2021. 5 funds tracked by Wall St. Rank hold SQZ as of Q3 2023.

State Street reported no remaining SQZ Biotechnologies Company position as of Q3 2023 after selling out during the quarter.
State Street sold 56,140 SQZ Biotechnologies Company shares in Q3 2023, an estimated $15.2K.
State Street first reported a position in SQZ Biotechnologies Company in Q4 2020 and held it in 11 quarters.
State Street's SQZ Biotechnologies Company position peaked at $4.72M in Q3 2021.
5 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q3 2023.

Based on State Street's 13F filing for Q3 2023, filed 14 Nov 2023.